Insights and events
Legal 500 Germany, 2021
"Broad and deep expertise, very great knowledge of the industry." Client
If you work in the pharma, medical devices or biotech sector, it is Jörg Schickert who will be solving all your most complicated regulatory, commercial and compliance issues – for both Germany and all of Europe. His long-standing experience in dealing with German and European pharmaceutical and devices law means that he can circumspectly navigate you through all your reimbursement or pricing and reimbursement challenges. He will also aid you in drafting commercial/licensing contracts. Furthermore, you may turn to him with any most delicate criminal and compliance cases which your company might face. Jörg is very practical and always offers business-oriented solutions. He takes his industry knowledge from 20 years' experience in working hand-in-hand with many major and reputed life sciences companies.
Jörg is one of the few go-to lawyers in Europe for complex issues in the core business of the life sciences industry. He has a deep knowledge across all relevant legal areas of the day-to-day business of selling pharmaceutical products and devices or offering health solutions. This allows him to provide overall solutions for issues and projects which have implications in very different legal disciplines, such as regulatory, reimbursement, commercial, and compliance. He advises on reimbursement strategies, clinical trials, the launch and marketing of new products, dealing with health care professionals, anti-corruption/transparency, product safety and vigilance and related agreements and contracts. He also assists our corporate teams in transactions pertaining to the life science industry. The team is ranked most recently in band 1 by JUVE, Chambers Global/Europe and LMG Germany, as well as in preceding years.
Chambers Europe, 2021
Jörg Schickert has a wide-ranging practice and is noted for his expertise across intellectual property and regulatory compliance.
Advising a leading pharmaceutical company on its innovative approach re digital health solutions alongside its pharma product offering in 21 countries on 4 continents.
Advising a U.S. medical devices company on regulatory and commercial issues regarding the market launch of a gene test in 24 European countries.
Due diligence and advising the Spanish pharma company Esteve on its sale and purchase agreement regarding its acquisition of Riemser Pharma
Advising MorphoSys Ag in the drafting and negotiating of an agreement regarding the co-development and co-marketing as well as the out-licensing (ex-US) of its blood cancer product
Reimbursement advice regarding the (aut idem) substitution in the pharmacy and reference price groups concerning an active ingredient complex and biologic pharmaceuticals.
Strategic and on-going HCP compliance advice as well as compliance audit of US-based pharmaceutical company.
- Second State Exam in Law, Higher Regional Court of Nuremberg, 2001
- Dr. iur., Friedrich-Alexander University Erlangen-Nürnberg, 2000
- First State Exam in Law, Friedrich-Alexander University Erlangen-Nürnberg, 1996